News Daily News Side Effects of Statins Might Be Overstated: CTT Collaboration Michael O'Riordan February 12, 2026
News Daily News Symplicity Spyral Approved: FDA Clears Second Renal Denervation System Todd Neale November 20, 2023
News Daily News Medical Devices Cleared on Faulty Predicates More Likely to be Recalled Michael O'Riordan January 17, 2023
News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Daily News Most Patient-Reported Outcome Measures in CVD Fall Short L.A. McKeown September 23, 2022
News Daily News Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection L.A. McKeown August 23, 2022
News Daily News Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles Michael O'Riordan May 12, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Daily News FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon L.A. McKeown February 18, 2021
News Daily News FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries Shelley Wood February 16, 2021
News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Conference News STS 2020 TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge Yael L. Maxwell January 29, 2020
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News FDA Approves Lotus Edge, Ushering Third Device Into US Market Shelley Wood April 24, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2019 Caitlin E. Cox January 31, 2019
News Daily News FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients Yael L. Maxwell December 05, 2018
News Daily News CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence Caitlin E. Cox September 05, 2018